PRESS RELEASE: TRIAL SHOWS BENEFITS OF NEW ANTI-ARRHYTHMIC AGENT, DRONEDARONE, IN THE MANAGEMENT OF CARDIAC ARRHYTHMIA

PRESS RELEASE: TRIAL SHOWS BENEFITS OF NEW ANTI-ARRHYTHMIC AGENT, DRONEDARONE, IN THE MANAGEMENT OF CARDIAC ARRHYTHMIA Results of the EURIDIS trial announced at the European Society of Cardiology 2004 congress See attached document for more details ------------------------------------------------------------ Informasjonen er sendt gjennom Waymaker http://www.waymaker.no Nedenstående filer kan lastes ned: http://www.waymaker.net/bitonline/2004/08/30/20040830BIT20760/wkr0001.pdf Press release Sanofi - Synthelabo